Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Author information

Affiliations

  • 1. Department of Medicine, University of Alabama at Birmingham 35294, USA.
      Authors
    • Gao F 1
    (1 author)

ORCIDs linked to this article

Journal of Virology, 01 Mar 1996, 70(3):1651-1667
https://doi.org/10.1128/jvi.70.3.1651-1667.1996 PMID: 8627686 PMCID: PMC189989

Free full text in Europe PMC

Abstract 

Present knowledge of human immunodeficiency virus type 1 (HIV-1) envelope immunobiology has been derived almost exclusively from analyses of subtype B viruses, yet such viruses represent only a minority of strains currently spreading worldwide. To generate a more representative panel of genetically diverse envelope genes, we PCR amplified, cloned, and sequenced complete gp160 coding regions of 35 primary (peripheral blood mononuclear cell-propagated) HIV-1 isolates collected at major epicenters of the current AIDS pandemic. Analysis of their deduced amino acid sequences revealed several important differences from prototypic subtype B strains, including changes in the number and distribution of cysteine residues, substantial length differences in hypervariable regions, and premature truncations in the gp41 domain. Moreover, transiently expressed glycoprotein precursor molecules varied considerably in both size and carbohydrate content. Phylogenetic analyses of full-length env sequences indicated that the panel included members of all major sequence subtypes of HIV-1 group M (clades A to G), as well as an intersubtype recombinant (F/B) from an infected individual in Brazil. In addition, all subtype E and three subtype G viruses initially classified on the basis of partial env sequences were found to cluster in subtype A in the 3' half of their gp41 coding region, suggesting that they are also recombinant. The biological activity of PCR-derived env genes was examined in a single-round virus infectivity assay. This analysis identified 20 clones, including 1 from each subtype (or recombinant), which expressed fully functional envelope glycoproteins. One of these, derived from a patient with rapid CD4 cell decline, contained an amino acid substitution in a highly conserved endocytosis signal (Y721C), as mediated virus entry with very poor efficiency, although they did not contain sequence changes predicted to alter protein function. These results indicate that the env genes of primary HIV-1 isolates collected worldwide can vary considerably in their genetic, phylogenetic, and biological properties. The panel of env constructs described here should prove valuable for future structure-function studies of naturally occurring envelope glycoproteins as well as AIDS vaccine development efforts targeted against a broader spectrum of viruses.

Free full text 

Logo of jvirolLink to Publisher's site
PMCID: PMC189989
PMID: 8627686

Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

F Gao, S G Morrison, D L Robertson, C L Thornton, S Craig, G Karlsson, J Sodroski, M Morgado, B Galvao-Castro, H von Briesen
Author information Copyright and License information Disclaimer

Abstract

Present knowledge of human immunodeficiency virus type 1 (HIV-1) envelope immunobiology has been derived almost exclusively from analyses of subtype B viruses, yet such viruses represent only a minority of strains currently spreading worldwide. To generate a more representative panel of genetically diverse envelope genes, we PCR amplified, cloned, and sequenced complete gp160 coding regions of 35 primary (peripheral blood mononuclear cell-propagated) HIV-1 isolates collected at major epicenters of the current AIDS pandemic. Analysis of their deduced amino acid sequences revealed several important differences from prototypic subtype B strains, including changes in the number and distribution of cysteine residues, substantial length differences in hypervariable regions, and premature truncations in the gp41 domain. Moreover, transiently expressed glycoprotein precursor molecules varied considerably in both size and carbohydrate content. Phylogenetic analyses of full-length env sequences indicated that the panel included members of all major sequence subtypes of HIV-1 group M (clades A to G), as well as an intersubtype recombinant (F/B) from an infected individual in Brazil. In addition, all subtype E and three subtype G viruses initially classified on the basis of partial env sequences were found to cluster in subtype A in the 3' half of their gp41 coding region, suggesting that they are also recombinant. The biological activity of PCR-derived env genes was examined in a single-round virus infectivity assay. This analysis identified 20 clones, including 1 from each subtype (or recombinant), which expressed fully functional envelope glycoproteins. One of these, derived from a patient with rapid CD4 cell decline, contained an amino acid substitution in a highly conserved endocytosis signal (Y721C), as mediated virus entry with very poor efficiency, although they did not contain sequence changes predicted to alter protein function. These results indicate that the env genes of primary HIV-1 isolates collected worldwide can vary considerably in their genetic, phylogenetic, and biological properties. The panel of env constructs described here should prove valuable for future structure-function studies of naturally occurring envelope glycoproteins as well as AIDS vaccine development efforts targeted against a broader spectrum of viruses.

Full Text

The Full Text of this article is available as a PDF (847K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abimiku AG, Stern TL, Zwandor A, Markham PD, Calef C, Kyari S, Saxinger WC, Gallo RC, Robert-Guroff M, Reitz MS. Subgroup G HIV type 1 isolates from Nigeria. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1581–1583. [Abstract] [Google Scholar]
  • Alizon M, Wain-Hobson S, Montagnier L, Sonigo P. Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell. 1986 Jul 4;46(1):63–74. [Abstract] [Google Scholar]
  • Baskar PV, Ray SC, Rao R, Quinn TC, Hildreth JE, Bollinger RC. Presence in India of HIV type 1 similar to North American strains. AIDS Res Hum Retroviruses. 1994 Aug;10(8):1039–1041. [Abstract] [Google Scholar]
  • Bobkov A, Cheingsong-Popov R, Garaev M, Rzhaninova A, Kaleebu P, Beddows S, Bachmann MH, Mullins JI, Louwagie J, Janssens W, et al. Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS. 1994 Dec;8(12):1649–1655. [Abstract] [Google Scholar]
  • Bobkov A, Garaev MM, Rzhaninova A, Kaleebu P, Pitman R, Weber JN, Cheingsong-Popov R. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data. AIDS. 1994 May;8(5):619–624. [Abstract] [Google Scholar]
  • Hoth DF, Bolognesi DP, Corey L, Vermund SH. NIH conference. HIV vaccine development: a progress report. Ann Intern Med. 1994 Oct 15;121(8):603–611. [Abstract] [Google Scholar]
  • Bruce C, Clegg C, Featherstone A, Smith J, Biryahawaho B, Downing R, Oram J. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1543–1550. [Abstract] [Google Scholar]
  • Charneau P, Borman AM, Quillent C, Guétard D, Chamaret S, Cohen J, Rémy G, Montagnier L, Clavel F. Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology. 1994 Nov 15;205(1):247–253. [Abstract] [Google Scholar]
  • Delwart EL, Shpaer EG, Louwagie J, McCutchan FE, Grez M, Rübsamen-Waigmann H, Mullins JI. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993 Nov 19;262(5137):1257–1261. [Abstract] [Google Scholar]
  • Dietrich U, Grez M, von Briesen H, Panhans B, Geissendörfer M, Kühnel H, Maniar J, Mahambre G, Becker WB, Becker ML, et al. HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate. AIDS. 1993 Jan;7(1):23–27. [Abstract] [Google Scholar]
  • Dubay JW, Roberts SJ, Hahn BH, Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J Virol. 1992 Nov;66(11):6616–6625. [Europe PMC free article] [Abstract] [Google Scholar]
  • Dumitrescu O, Kalish ML, Kliks SC, Bandea CI, Levy JA. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. J Infect Dis. 1994 Feb;169(2):281–288. [Abstract] [Google Scholar]
  • Faulkner DV, Jurka J. Multiple aligned sequence editor (MASE). Trends Biochem Sci. 1988 Aug;13(8):321–322. [Abstract] [Google Scholar]
  • Fuerst TR, Niles EG, Studier FW, Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122–8126. [Europe PMC free article] [Abstract] [Google Scholar]
  • Gabuzda DH, Lever A, Terwilliger E, Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J Virol. 1992 Jun;66(6):3306–3315. [Europe PMC free article] [Abstract] [Google Scholar]
  • Gao F, Yue L, Craig S, Thornton CL, Robertson DL, McCutchan FE, Bradac JA, Sharp PM, Hahn BH. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1359–1368. [Abstract] [Google Scholar]
  • Gao F, Yue L, Hill SC, Robertson DL, Graves AH, Saag MS, Shaw GM, Sharp PM, Hahn BH. HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses. 1994 May;10(5):625–627. [Abstract] [Google Scholar]
  • Graham BS, Wright PF. Candidate AIDS vaccines. N Engl J Med. 1995 Nov 16;333(20):1331–1339. [Abstract] [Google Scholar]
  • Grez M, Dietrich U, Balfe P, von Briesen H, Maniar JK, Mahambre G, Delwart EL, Mullins JI, Rübsamen-Waigmann H. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol. 1994 Apr;68(4):2161–2168. [Europe PMC free article] [Abstract] [Google Scholar]
  • Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, Kaptue L. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol. 1994 Mar;68(3):1581–1585. [Europe PMC free article] [Abstract] [Google Scholar]
  • Haynes BF. Scientific and social issues of human immunodeficiency virus vaccine development. Science. 1993 May 28;260(5112):1279–1286. [Abstract] [Google Scholar]
  • Helseth E, Kowalski M, Gabuzda D, Olshevsky U, Haseltine W, Sodroski J. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J Virol. 1990 May;64(5):2416–2420. [Europe PMC free article] [Abstract] [Google Scholar]
  • Higgins DG, Sharp PM. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci. 1989 Apr;5(2):151–153. [Abstract] [Google Scholar]
  • Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989 Dec 14;321(24):1621–1625. [Abstract] [Google Scholar]
  • Jain MK, John TJ, Keusch GT. A review of human immunodeficiency virus infection in India. J Acquir Immune Defic Syndr. 1994 Nov;7(11):1185–1194. [Abstract] [Google Scholar]
  • Jameel S, Zafrullah M, Ahmad M, Kapoor GS, Sehgal S. A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants. AIDS. 1995 Jul;9(7):685–690. [Abstract] [Google Scholar]
  • Janssens W, Heyndrickx L, Van de Peer Y, Bouckaert A, Fransen K, Motte J, Gershy-Damet GM, Peeters M, Piot P, van der Groen G. Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS. 1994 Jan;8(1):21–26. [Abstract] [Google Scholar]
  • Janssens W, Heyndrickx L, Fransen K, Motte J, Peeters M, Nkengasong JN, Ndumbe PM, Delaporte E, Perret JL, Atende C, et al. Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retroviruses. 1994 Jul;10(7):877–879. [Abstract] [Google Scholar]
  • Janssens W, Heyndrickx L, Fransen K, Temmerman M, Leonaers A, Ivens T, Motte J, Piot P, Van der Groen G. Genetic variability of HIV type 1 in Kenya. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1577–1579. [Abstract] [Google Scholar]
  • Kaleebu P, Bobkov A, Cheingsong-Popov R, Bieniasz P, Garaev M, Weber J. Identification of HIV-1 subtype G from Uganda. AIDS Res Hum Retroviruses. 1995 May;11(5):657–659. [Abstract] [Google Scholar]
  • Kalish ML, Luo CC, Weniger BG, Limpakarnjanarat K, Young N, Ou CY, Schochetman G. Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1573–1575. [Abstract] [Google Scholar]
  • Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980 Dec;16(2):111–120. [Abstract] [Google Scholar]
  • Korber BT, Allen EE, Farmer AD, Myers GL. Heterogeneity of HIV-1 and HIV-2. AIDS. 1995;9 (Suppl A):S5–18. [Abstract] [Google Scholar]
  • Korber BT, Learn G, Mullins JI, Hahn BH, Wolinsky S. Protecting HIV databases. Nature. 1995 Nov 16;378(6554):242–244. [Abstract] [Google Scholar]
  • Korber BT, MacInnes K, Smith RF, Myers G. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol. 1994 Oct;68(10):6730–6744. [Europe PMC free article] [Abstract] [Google Scholar]
  • Korber BT, Osmanov S, Esparza J, Myers G. The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1355–1358. [Abstract] [Google Scholar]
  • Kostrikis LG, Bagdades E, Cao Y, Zhang L, Dimitriou D, Ho DD. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J Virol. 1995 Oct;69(10):6122–6130. [Europe PMC free article] [Abstract] [Google Scholar]
  • Kostrikis LG, Cao Y, Ngai H, Moore JP, Ho DD. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J Virol. 1996 Jan;70(1):445–458. [Europe PMC free article] [Abstract] [Google Scholar]
  • Kuiken CL, Zwart G, Baan E, Coutinho RA, van den Hoek JA, Goudsmit J. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9061–9065. [Europe PMC free article] [Abstract] [Google Scholar]
  • Kunanusont C, Foy HM, Kreiss JK, Rerks-Ngarm S, Phanuphak P, Raktham S, Pau CP, Young NL. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet. 1995 Apr 29;345(8957):1078–1083. [Abstract] [Google Scholar]
  • Kusumi K, Conway B, Cunningham S, Berson A, Evans C, Iversen AK, Colvin D, Gallo MV, Coutre S, Shpaer EG, et al. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J Virol. 1992 Feb;66(2):875–885. [Europe PMC free article] [Abstract] [Google Scholar]
  • LaBranche CC, Sauter MM, Haggarty BS, Vance PJ, Romano J, Hart TK, Bugelski PJ, Marsh M, Hoxie JA. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J Virol. 1995 Sep;69(9):5217–5227. [Europe PMC free article] [Abstract] [Google Scholar]
  • Leitner T, Alaeus A, Marquina S, Lilja E, Lidman K, Albert J. Yet another subtype of HIV type 1? AIDS Res Hum Retroviruses. 1995 Aug;11(8):995–997. [Abstract] [Google Scholar]
  • Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem. 1990 Jun 25;265(18):10373–10382. [Abstract] [Google Scholar]
  • Li WH, Tanimura M, Sharp PM. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol Biol Evol. 1988 Jul;5(4):313–330. [Abstract] [Google Scholar]
  • Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol. 1991 Aug;65(8):3973–3985. [Europe PMC free article] [Abstract] [Google Scholar]
  • Lodge R, Göttlinger H, Gabuzda D, Cohen EA, Lemay G. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol. 1994 Aug;68(8):4857–4861. [Europe PMC free article] [Abstract] [Google Scholar]
  • Loussert-Ajaka I, Chaix ML, Korber B, Letourneur F, Gomas E, Allen E, Ly TD, Brun-Vézinet F, Simon F, Saragosti S. Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol. 1995 Sep;69(9):5640–5649. [Europe PMC free article] [Abstract] [Google Scholar]
  • Louwagie J, Janssens W, Mascola J, Heyndrickx L, Hegerich P, van der Groen G, McCutchan FE, Burke DS. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol. 1995 Jan;69(1):263–271. [Europe PMC free article] [Abstract] [Google Scholar]
  • Louwagie J, McCutchan FE, Peeters M, Brennan TP, Sanders-Buell E, Eddy GA, van der Groen G, Fransen K, Gershy-Damet GM, Deleys R, et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS. 1993 Jun;7(6):769–780. [Abstract] [Google Scholar]
  • Lydy SL, Compans RW. Role of the cytoplasmic domains of viral glycoproteins in antibody-induced cell surface mobility. J Virol. 1993 Oct;67(10):6289–6294. [Europe PMC free article] [Abstract] [Google Scholar]
  • Mammano F, Kondo E, Sodroski J, Bukovsky A, Göttlinger HG. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J Virol. 1995 Jun;69(6):3824–3830. [Europe PMC free article] [Abstract] [Google Scholar]
  • McCutchan FE, Hegerich PA, Brennan TP, Phanuphak P, Singharaj P, Jugsudee A, Berman PW, Gray AM, Fowler AK, Burke DS. Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses. 1992 Nov;8(11):1887–1895. [Abstract] [Google Scholar]
  • McCutchan FE, Ungar BL, Hegerich P, Roberts CR, Fowler AK, Hira SK, Perine PL, Burke DS. Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1. J Acquir Immune Defic Syndr. 1992;5(5):441–449. [Abstract] [Google Scholar]
  • Miotti P, Canner J, Chiphangwi J, Liomba G, Saah A, Dallabetta G. Preparations for AIDS vaccine evaluations. Rate of new HIV infection in a cohort of women of childbearing age in Malawi. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S239–S241. [Abstract] [Google Scholar]
  • Modrow S, Hahn BH, Shaw GM, Gallo RC, Wong-Staal F, Wolf H. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol. 1987 Feb;61(2):570–578. [Europe PMC free article] [Abstract] [Google Scholar]
  • Moore J, Anderson R. The WHO and why of HIV vaccine trials. Nature. 1994 Nov 24;372(6504):313–314. [Abstract] [Google Scholar]
  • Moore JP. HIV vaccines. Back to primary school. Nature. 1995 Jul 13;376(6536):115–115. [Abstract] [Google Scholar]
  • Moore JP, Cao Y, Qing L, Sattentau QJ, Pyati J, Koduri R, Robinson J, Barbas CF, 3rd, Burton DR, Ho DD. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol. 1995 Jan;69(1):101–109. [Europe PMC free article] [Abstract] [Google Scholar]
  • Moore JP, Ho DD. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS. 1995;9 (Suppl A):S117–S136. [Abstract] [Google Scholar]
  • Morgado MG, Sabino EC, Shpaer EG, Bongertz V, Brigido L, Guimaraes MD, Castilho EA, Galvão-Castro B, Mullins JI, Hendry RM, et al. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses. 1994 May;10(5):569–576. [Abstract] [Google Scholar]
  • Morrow CD, Porter DC, Ansardi DC, Moldoveanu Z, Fultz PN. New approaches for mucosal vaccines for AIDS: encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S61–S66. [Abstract] [Google Scholar]
  • Murphy E, Korber B, Georges-Courbot MC, You B, Pinter A, Cook D, Kieny MP, Georges A, Mathiot C, Barré-Sinoussi F, et al. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. AIDS Res Hum Retroviruses. 1993 Oct;9(10):997–1006. [Abstract] [Google Scholar]
  • Myers G. Tenth anniversary perspectives on AIDS. HIV: between past and future. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1317–1324. [Abstract] [Google Scholar]
  • Nelson KE, Vlahov D, Galai N, Astemborski J, Solomon L. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S201–S205. [Abstract] [Google Scholar]
  • Nelson KE, Beyrer C, Natpratan C, Eiumtrakul S, Celentano DD, Khamboonruang C. Preparatory studies for possible HIV vaccine trials in northern Thailand. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S243–S246. [Abstract] [Google Scholar]
  • Nkengasong JN, Janssens W, Heyndrickx L, Fransen K, Ndumbe PM, Motte J, Leonaers A, Ngolle M, Ayuk J, Piot P, et al. Genotypic subtypes of HIV-1 in Cameroon. AIDS. 1994 Oct;8(10):1405–1412. [Abstract] [Google Scholar]
  • Olshevsky U, Helseth E, Furman C, Li J, Haseltine W, Sodroski J. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol. 1990 Dec;64(12):5701–5707. [Europe PMC free article] [Abstract] [Google Scholar]
  • Ou CY, Takebe Y, Weniger BG, Luo CC, Kalish ML, Auwanit W, Yamazaki S, Gayle HD, Young NL, Schochetman G. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet. 1993 May 8;341(8854):1171–1174. [Abstract] [Google Scholar]
  • Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP, et al. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature. 1994 Aug 11;370(6489):463–467. [Abstract] [Google Scholar]
  • Piatak M, Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS. 1993 Nov;7 (Suppl 2):S65–S71. [Abstract] [Google Scholar]
  • Piatak M, Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993 Mar 19;259(5102):1749–1754. [Abstract] [Google Scholar]
  • Porter DC, Ansardi DC, Choi WS, Morrow CD. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. J Virol. 1993 Jul;67(7):3712–3719. [Europe PMC free article] [Abstract] [Google Scholar]
  • Potts KE, Kalish ML, Bandea CI, Orloff GM, St Louis M, Brown C, Malanda N, Kavuka M, Schochetman G, Ou CY, et al. Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire. AIDS Res Hum Retroviruses. 1993 Jul;9(7):613–618. [Abstract] [Google Scholar]
  • Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol. 1995 Mar;40(3):249–259. [Abstract] [Google Scholar]
  • Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature. 1995 Mar 9;374(6518):124–126. [Abstract] [Google Scholar]
  • Rowell JF, Stanhope PE, Siliciano RF. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol. 1995 Jul 1;155(1):473–488. [Abstract] [Google Scholar]
  • Rübsamen-Waigmann H, von Briesen H, Holmes H, Björndal A, Korber B, Esser R, Ranjbar S, Tomlinson P, Galvao-Castro B, Karita E, et al. Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1401–1408. [Abstract] [Google Scholar]
  • Ruff AJ, Coberly J, Halsey NA, Boulos R, Desormeaux J, Burnley A, Joseph DJ, McBrien M, Quinn T, Losikoff P, et al. Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. J Acquir Immune Defic Syndr. 1994 Jan;7(1):68–73. [Abstract] [Google Scholar]
  • Sabino EC, Shpaer EG, Morgado MG, Korber BT, Diaz RS, Bongertz V, Cavalcante S, Galvão-Castro B, Mullins JI, Mayer A. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol. 1994 Oct;68(10):6340–6346. [Europe PMC free article] [Abstract] [Google Scholar]
  • Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987 Jul;4(4):406–425. [Abstract] [Google Scholar]
  • Sharp PM, Robertson DL, Hahn BH. Cross-species transmission and recombination of 'AIDS' viruses. Philos Trans R Soc Lond B Biol Sci. 1995 Jul 29;349(1327):41–47. [Abstract] [Google Scholar]
  • Smith RF, Smith TF. Automatic generation of primary sequence patterns from sets of related protein sequences. Proc Natl Acad Sci U S A. 1990 Jan;87(1):118–122. [Europe PMC free article] [Abstract] [Google Scholar]
  • Smith RF, Smith TF. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling. Protein Eng. 1992 Jan;5(1):35–41. [Abstract] [Google Scholar]
  • Spire B, Sire J, Zachar V, Rey F, Barré-Sinoussi F, Galibert F, Hampe A, Chermann JC. Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene. 1989 Sep 30;81(2):275–284. [Abstract] [Google Scholar]
  • Sullivan N, Sun Y, Li J, Hofmann W, Sodroski J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J Virol. 1995 Jul;69(7):4413–4422. [Europe PMC free article] [Abstract] [Google Scholar]
  • Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994 Nov 11;22(22):4673–4680. [Europe PMC free article] [Abstract] [Google Scholar]
  • Vanden Haesevelde M, Decourt JL, De Leys RJ, Vanderborght B, van der Groen G, van Heuverswijn H, Saman E. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol. 1994 Mar;68(3):1586–1596. [Europe PMC free article] [Abstract] [Google Scholar]
  • Warren JT, Dolatshahi M. Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. J Med Primatol. 1994 Feb-May;23(2-3):184–225. [Abstract] [Google Scholar]
  • Wrin T, Nunberg JH. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals. AIDS. 1994 Nov;8(11):1622–1623. [Abstract] [Google Scholar]
  • Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol. 1995 Sep;69(9):5723–5733. [Europe PMC free article] [Abstract] [Google Scholar]
  • Yahi N, Fantini J, Hirsch I, Chermann JC. Structural variability of env and gag gene products from a highly cytopathic strain of HIV-1. Arch Virol. 1992;125(1-4):287–298. [Abstract] [Google Scholar]
  • Yu X, Yuan X, McLane MF, Lee TH, Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J Virol. 1993 Jan;67(1):213–221. [Europe PMC free article] [Abstract] [Google Scholar]
Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

Full text links 

Read article at publisher's site: https://doi.org/10.1128/jvi.70.3.1651-1667.1996

Read article for free, from open access legal sources, via Unpaywall: https://jvi.asm.org/content/jvi/70/3/1651.full.pdfUnpaywall

Free to read at jvi.asm.org
http://jvi.asm.org/cgi/content/abstract/70/3/1651

Free after 4 months at jvi.asm.org
http://jvi.asm.org/cgi/reprint/70/3/1651

Citations & impact 

Impact metrics

220
Citations
Jump to Citations
20
Data citations
Jump to Data

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/5382741
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/5382741

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1128/jvi.70.3.1651-1667.1996

Supporting
Mentioning
Contrasting
1
61
0

Article citations

Go to all (220) article citations

Data 

Data behind the article

This data has been text mined from the article, or deposited into data resources.

BioStudies: supplemental material and supporting data

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

NIAID NIH HHS (3)